Researchers have used a noninvasive tool to detect small blood vessel disease in the brain of SCD patients, according to a ...
DENVER, April 08, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients ...
Conducted in 148 centers in Canada, New Zealand, and the United States between September 1997 and July 2001, SCD-HeFT involved a total of 2521 patients with dilated cardiomyopathy, with or without ...
Pfizer’s sickle cell disease (SCD) drug has flunked a key phase 3 test, the latest blow to the pharma’s $5.4 billion acquisition of Global Blood Therapeutics. Pfizer acquired the P-selectin inhibitor, ...
Sickle cell disease (SCD) altered CD8+ T-cell chromatin architecture, triggering ferroptosis and weakening antitumor immunity. Hydrogen sulfide (H2S) treatment restored chromatin interactions and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback